According to Sun Pharmaceutical 's latest financial reports and stock price the company's current price-to-sales ratio (TTM) is 5.88. At the end of 2024 the company had a P/S ratio of 8.62.
Year | P/S ratio | Change |
---|---|---|
2024 | 8.62 | 33.88% |
2023 | 6.44 | 16.46% |
2022 | 5.53 | 2.45% |
2021 | 5.39 | 22.47% |
2020 | 4.40 | 35.19% |
2019 | 3.26 | -9.29% |
2018 | 3.59 | -32.04% |
2017 | 5.28 | 8.82% |
2016 | 4.86 | -32.84% |
2015 | 7.23 | 10.04% |
2014 | 6.57 | -13.22% |
2013 | 7.57 | 6.59% |
2012 | 7.11 |